- Todos > Medicine Access and Rational Use > Antimicrobial Drug Resistance
- Todos > Medicine Access and Rational Use > Rational Use
- Palabras clave > antimicrobial resistance (AMR)
- Palabras clave > antiretroviral therapy (ART)
- Palabras clave > antiretrovirals
- Palabras clave > containment of antimicrobial resistance
- Palabras clave > drug resistance in ARV
- Palabras clave > HIV/AIDS
- Palabras clave > Multidrug-resistant Tuberculosis (MDR-TB)
- Palabras clave > pharmaceutical management - antiretroviral medicines (ARV)
- Palabras clave > rational use of medicines (RUM) / rational medicine use (RMU)
- Palabras clave > confinement antimicrobien
(2013; 82 pages)
Mabirizi, D, Kibuule D, Adorka M, et al. Promoting the Rational Medicine Use of ARVs, Anti-TB, and Other Medicines and Preventing the Development of Antimicrobial Resistance in Namibia: Workshop and Stakeholders Forum. Developed in collaboration with the University of Namibia-School of Pharmacy and Ministry of Health and Social Services, Division of Pharmaceutical Services. Submitted to USAID by the SIAPS Program. Arlington, VA: Management Sciences for Health, 2013.
Namibia has adopted the public health approach to scaling up antiretroviral therapy (ART) that involves the use of standardized and simplified treatment regimens. Drug resistance (DR) to antiretroviral (ARVs) medications is inevitable in populations on life-long ART. Namibia is one of the three countries in Africa (in addition to Botswana and Rwanda) that has reached 80 percent coverage for ART (Joint United Nations Programme on HIV/AIDS – UNAIDS, 2011). Containing AMR is a key focus of the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program in Namibia. SIAPS proposes to work with UNAM SOP, MoHSS, and other stakeholders to strengthen local initiatives and networks to help prevent the development and spread of resistance to ARV, anti-TB, and other antimicrobial agents.